Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Global Health's share price for the quarter that ended in Jun. 2026 was ₹1314.6. Global Health's Shares Outstanding (EOP) for the quarter that ended in Jun. 2026 was 269 Mil. Therefore, Global Health's market cap for the quarter that ended in Jun. 2026 was ₹353,258 Mil.
Global Health's quarterly market cap
declined
from Dec. 2025 (₹318,590 Mil) to Mar. 2026 (₹258,362 Mil) but then
increased
from Mar. 2026 (₹258,362 Mil) to Jun. 2026 (₹353,258 Mil).
Global Health's annual market cap
declined
from Mar. 2024 (₹355,423 Mil) to Mar. 2025 (₹321,821 Mil) and
declined
from Mar. 2025 (₹321,821 Mil) to Mar. 2026 (₹258,362 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Global Health's Enterprise Value for Today is ₹378,537 Mil.
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Global Health Market Cap Related Terms
Global Health Market Cap Historical Data
* Premium members only.
The historical data trend for Global Health's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:543654 vs HCA, THC, DVA: Market Cap Comparison
For the Medical Care Facilities subindustry, Global Health's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Global Health Market Cap vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Global Health's Market Cap distribution charts can be found below:
* The bar in red indicates where Global Health's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Global Health's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Global Health (BOM:543654) has a Market Cap of ₹377,469 Mil as of Aug. 26, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Global Health and its competitors. According to the industry distribution chart, Global Health ranks #47 out of 694 companies in the Healthcare Providers & Services industry, placing it in the top 6.8%.
Is Global Health's Market Cap too high?
Global Health's current Market Cap is ₹377,469 Mil. Based on the distribution chart, Global Health ranks #47 out of 694 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Global Health has a GF Score™ of 97/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Global Health's Market Cap compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Global Health ranks #47 out of 694 companies for Market Cap. This places Global Health in the top 7% of its industry — outperforming the majority of peers. The industry median Market Cap is 106.59. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 106.59, based on 694 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Global Health and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 106.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Global Health's current Market Cap is ₹377,469 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Global Health stock overvalued right now?
Based on GuruFocus' analysis, Global Health (BOM:543654) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹1,562.98, compared to a current price of ₹1,404.70 — trading 10.1% below its estimated fair value. The current Market Cap is ₹377,469 Mil. Global Health's overall GF Score™ is 97/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Global Health (BOM:543654), the current Market Cap is ₹377,469 Mil as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Global Health (BOM:543654) Overvalued in 2026?
Based on GuruFocus' analysis, Global Health stock appears to be undervalued.
The current stock price of ₹1,404.70 is trading 10.1% below its estimated GF Value™ of ₹1,562.98.
GuruFocus considers Global Health to be Modestly Undervalued.
Key valuation signals for BOM:543654:
Market Cap: ₹377,469 Mil
GF Value™: ₹1,562.98 vs. price of ₹1,404.70 (10.1% below fair value)
No single metric tells the full story. See the BOM:543654 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Global Health Ltd operates as a private multi-specialty tertiary care provider operating in the North and East regions of India, with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplant, and kidney and urology. Under the Medanta brand, it has a network of hospitals in operation (Gurugram, Indore, Ranchi, and Lucknow), a hospital that is under construction with an operational outpatient facility (Patna), and a hospital (Noida) planned for development. The Group operates Healthcare services as a single business segment in India, constituting a single geographical segment.
97GF Score
Get the complete analysis for BOM:543654
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543654 has been successfully added to your 
